| Acne Vulgaris
Aklief vs Twyneo
Side-by-side clinical, coverage, and cost comparison for acne vulgaris.Deep comparison between: Aklief vs Twyneo with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsTwyneo has a higher rate of injection site reactions vs Aklief based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Twyneo but not Aklief, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Aklief
Twyneo
At A Glance
Topical
Once daily
Retinoid (RAR agonist)
Topical
Once daily
Retinoid/benzoyl peroxide combination
Indications
- Acne Vulgaris
- Acne Vulgaris
Dosing
Acne Vulgaris Apply a thin layer once daily in the evening to clean, dry skin; one pump actuation for the face, two for the upper trunk, with an optional additional actuation for the middle and lower back; avoid contact with eyes, lips, paranasal creases, and mucous membranes.
Acne Vulgaris Apply a thin layer to the affected areas once daily on clean and dry skin; avoid contact with eyes, lips, paranasal creases, and mucous membranes; wash hands after application.
Contraindications
—
- History of hypersensitivity reaction to benzoyl peroxide or any components of TWYNEO
Adverse Reactions
Most common (>=1%) Application site irritation, application site pruritus, sunburn
Most common (>=1%) Application site pain (stinging, burning, or pain), dryness, exfoliation, erythema, dermatitis, pruritus, irritation
Postmarketing Anaphylaxis, angioedema, urticaria (reported with benzoyl peroxide)
Pharmacology
Trifarotene is a retinoic acid receptor (RAR) agonist with particular activity at the gamma subtype; stimulation of RAR modulates target genes associated with cell differentiation and inflammation.
Benzoyl peroxide is an oxidizing agent with bactericidal and keratolytic effects; tretinoin is a retinoid that binds retinoic acid nuclear receptors (RARalpha, RARbeta, RARgamma), modifying gene expression, protein synthesis, and epithelial cell growth and differentiation, and decreasing cohesiveness of follicular epithelial cells to reduce microcomedo formation.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Aklief
- Covered on 5 commercial plans
- PA (6/12) · Step Therapy (10/12) · Qty limit (9/12)
Twyneo
- Covered on 5 commercial plans
- PA (10/12) · Step Therapy (9/12) · Qty limit (9/12)
UnitedHealthcare
Aklief
- Covered on 4 commercial plans
- PA (5/8) · Step Therapy (0/8) · Qty limit (4/8)
Twyneo
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (1/8) · Qty limit (0/8)
Humana
Aklief
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (0/3) · Qty limit (2/3)
Twyneo
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (0/3) · Qty limit (2/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Aklief.
No savings programs available for Twyneo.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
AkliefView full Aklief profile
TwyneoView full Twyneo profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.